AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 53 filers reported holding AGILE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $176,000 | -1.7% | 30,851 | +20.4% | 0.01% | 0.0% |
| Q3 2016 | $179,000 | -7.3% | 25,631 | +1.2% | 0.01% | -18.2% |
| Q2 2016 | $193,000 | +22.2% | 25,317 | -0.8% | 0.01% | +22.2% |
| Q1 2016 | $158,000 | -37.5% | 25,523 | -1.5% | 0.01% | -35.7% |
| Q4 2015 | $253,000 | – | 25,917 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 15,919,925 | $33,113,000 | 0.42% |
| INVESTOR AB | 3,510,189 | $7,301,000 | 0.26% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 735,000 | $1,529,000 | 0.21% |
| FIRST MIDWEST BANK TRUST DIVISION | 578,864 | $1,204,000 | 0.17% |
| PREMIER ASSET MANAGEMENT LLC | 224,559 | $467,000 | 0.08% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 100,000 | $208,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 140,015 | $291,000 | 0.05% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 25,000 | $52,000 | 0.01% |
| Kalos Management, Inc. | 19,250 | $35,000 | 0.01% |
| Founders Capital Management | 5,000 | $10,000 | 0.01% |